LCN2 and chronic kidney disease: Although plasma NGAL was not as good as mitochondrial parameters in early detecting the CI‐AKI in patients receiving contrast media, this subgroup analysis indicated that increased plasma NGAL could be used as a marker of CI‐AKI in CKD patients.